All News about Supernus Pharm
Supernus Announces Third Quarter 2022 Financial Results
November 08, 2022
Via GlobeNewswire
FDA Rejects Supernus Pharma's Minimally Invasive Parkinson's Therapy
October 10, 2022
Via Benzinga
Supernus Provides Regulatory Update on SPN-830
October 10, 2022
Via GlobeNewswire
Via Benzinga
Via Benzinga
Supernus Pharmaceuticals, inc (SUPN) Q3 2021 Earnings Call Transcript
November 04, 2021
Via The Motley Fool
Topics
Earnings
Exposures
Financial
The Daily Biotech Pulse: Cerus Climbs On Earnings, Horizon CFO To Retire, Teva Prices Upsized Sustainability-Linked Senior Note Offering
November 03, 2021
Via Benzinga
Topics
Retirement
Exposures
Pension
Mid-Afternoon Market Update: Dow Tumbles Over 100 Points; Flexion Therapeutics Shares Spike Higher
October 11, 2021
Via Talk Markets
Topics
Stocks
Exposures
US Equities
Mid-Afternoon Market Update: Dow Tumbles Over 100 Points; Flexion Therapeutics Shares Spike Higher
October 11, 2021
Via Benzinga
Topics
Stocks
Exposures
US Equities
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.